A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease
Condition:   Sickle Cell DiseaseInterventions:   Other: Blood draw;   Other: Nasopharyngeal washSponsors:   St. Jude Children's Research Hospital;   Novartis Vaccines;   National Heart, Lung, and Blood Institute (NHLBI)Not yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2014 Category: Research Source Type: clinical trials

A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease
Condition:   Sickle Cell DiseaseInterventions:   Other: Blood draw;   Other: Nasopharyngeal washSponsors:   St. Jude Children's Research Hospital;   Novartis Vaccines;   National Heart, Lung, and Blood Institute (NHLBI)Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2014 Category: Research Source Type: clinical trials

Intravenous Immunoglobulin (IVIg) for Parvovirus B19(PVB19) Mediated Cardiomyopathy
Conditions:   Myocardial Diseases;   PVB19 Viral LoadInterventions:   Drug: Intravenous Immunoglobulins;   Drug: plasma volume expanderSponsors:   Sanquin;   SanquinRecruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2009 Category: Research Source Type: clinical trials

Intravenous Immunoglobulin (IVIg) for Parvovirus B19(PVB19) Mediated Cardiomyopathy
Conditions:   Myocardial Diseases;   PVB19Interventions:   Drug: Intravenous Immunoglobulins;   Drug: plasma volume expanderSponsor:   SanquinRecruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2009 Category: Research Source Type: clinical trials